DE69828596D1 - Waessrige zusammensetzungen die einen lipidstoff und ein tensid auf lanolinbasis enthalten und ihre verwendung - Google Patents

Waessrige zusammensetzungen die einen lipidstoff und ein tensid auf lanolinbasis enthalten und ihre verwendung

Info

Publication number
DE69828596D1
DE69828596D1 DE69828596T DE69828596T DE69828596D1 DE 69828596 D1 DE69828596 D1 DE 69828596D1 DE 69828596 T DE69828596 T DE 69828596T DE 69828596 T DE69828596 T DE 69828596T DE 69828596 D1 DE69828596 D1 DE 69828596D1
Authority
DE
Germany
Prior art keywords
lanolin
waesserige
lanolinbasis
tensid
lipidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828596T
Other languages
English (en)
Other versions
DE69828596T2 (de
Inventor
Ian Steel
Stanley Kitchen
Ronald Flockhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRODA CHEMICALS INTERNAT Ltd G
Original Assignee
CRODA CHEMICALS INTERNAT Ltd G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRODA CHEMICALS INTERNAT Ltd G filed Critical CRODA CHEMICALS INTERNAT Ltd G
Application granted granted Critical
Publication of DE69828596D1 publication Critical patent/DE69828596D1/de
Publication of DE69828596T2 publication Critical patent/DE69828596T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69828596T 1997-04-22 1998-04-22 Waessrige zusammensetzungen die einen lipidstoff und ein tensid auf lanolinbasis enthalten und ihre verwendung Expired - Lifetime DE69828596T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9708066.7A GB9708066D0 (en) 1997-04-22 1997-04-22 Compositions and their use
GB9708066 1997-04-22
PCT/GB1998/001174 WO1998047468A1 (en) 1997-04-22 1998-04-22 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use

Publications (2)

Publication Number Publication Date
DE69828596D1 true DE69828596D1 (de) 2005-02-17
DE69828596T2 DE69828596T2 (de) 2005-12-01

Family

ID=10811121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828596T Expired - Lifetime DE69828596T2 (de) 1997-04-22 1998-04-22 Waessrige zusammensetzungen die einen lipidstoff und ein tensid auf lanolinbasis enthalten und ihre verwendung

Country Status (11)

Country Link
US (1) US6224853B1 (de)
EP (1) EP0977538B1 (de)
JP (1) JP4571241B2 (de)
AT (1) ATE286706T1 (de)
AU (1) AU728726B2 (de)
CA (1) CA2286837C (de)
DE (1) DE69828596T2 (de)
ES (1) ES2235327T3 (de)
GB (2) GB9708066D0 (de)
NZ (1) NZ500509A (de)
WO (1) WO1998047468A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022337D0 (en) * 2000-09-12 2000-10-25 Barrier Biotech Ltd An antimicrobial composition
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
CN1893926B (zh) * 2003-11-20 2010-09-08 Ym生物科学有限公司 包含含有药物成分的亲脂胺的稳定脂质体组合物
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
GB2425475A (en) * 2005-01-29 2006-11-01 Croda Int Plc PEG or PPG lanolin derivatives as antipruritic agents
CA2618655C (en) 2005-07-18 2015-12-22 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN103919690B (zh) 2005-12-01 2020-07-31 麻萨诸塞州洛厄尔大学 肉毒杆菌纳米乳液
US20100172943A1 (en) 2006-12-01 2010-07-08 Anterios, Inc. Peptide nanoparticles and uses therefor
MX2009005727A (es) * 2006-12-01 2009-08-27 Anterios Inc Nanoparticulas de entidad anfifilica.
EP2162117B1 (de) 2007-05-31 2018-02-21 Anterios, Inc. Nukleinsäure-nanoteilchen und ihre verwendungszwecke
CN102099475A (zh) * 2008-06-04 2011-06-15 科达治疗公司 用间隙连接调节化合物治疗疼痛
US20110212157A1 (en) * 2008-06-26 2011-09-01 Anterios, Inc. Dermal delivery
EP3269372B1 (de) 2012-01-19 2019-06-12 Hybrid Medical, LLC Topische therapeutische formulierungen
CA2868534A1 (en) 2012-03-27 2013-10-03 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
CA2873881A1 (en) 2012-05-18 2013-11-21 Stephen Bruce Fleming Combination treatments and compositions for wound healing
US20150182451A1 (en) * 2013-12-27 2015-07-02 The Dial Corporation Cleansing composition for hormone deposition
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666857A (en) * 1966-03-04 1972-05-30 Malmstrom Chem Corp Aqueous compositions containing lanolin oil
JPS5729213B2 (de) * 1974-11-12 1982-06-21
US5439672A (en) * 1980-07-01 1995-08-08 L'oreal Cosmetic composition based on an aqueous dispersion of small lipid spheres
US5489426A (en) * 1980-07-01 1996-02-06 L'oreal Cosmetic composition based on an aqueous dispersion of small lipid spheres
DE3161962D1 (en) * 1980-07-01 1984-02-23 Oreal Process for obtaining stable dispersions in an aqueous phase of at least a water immiscible liquid phase, and corresponding dispersions
DE3338890A1 (de) * 1983-10-27 1985-05-09 Beiersdorf Ag, 2000 Hamburg Neue o/w-emulgatoren fuer kosmetische zwecke
EP0349150B1 (de) 1988-06-20 1994-08-17 Shiseido Company Limited Durchsichtiges Präparat
CA2017507C (en) * 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
GB2297762A (en) * 1994-12-05 1996-08-14 Procter & Gamble Personal cleaning compositions

Also Published As

Publication number Publication date
GB2334446B (en) 2002-01-09
AU728726B2 (en) 2001-01-18
DE69828596T2 (de) 2005-12-01
CA2286837C (en) 2010-10-19
WO1998047468A1 (en) 1998-10-29
JP4571241B2 (ja) 2010-10-27
AU7066798A (en) 1998-11-13
ES2235327T3 (es) 2005-07-01
GB9913095D0 (en) 1999-08-04
GB2334446A (en) 1999-08-25
CA2286837A1 (en) 1998-10-29
ATE286706T1 (de) 2005-01-15
EP0977538A1 (de) 2000-02-09
GB9708066D0 (en) 1997-06-11
US6224853B1 (en) 2001-05-01
EP0977538B1 (de) 2005-01-12
NZ500509A (en) 2004-01-30
JP2001521547A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
DE69828596D1 (de) Waessrige zusammensetzungen die einen lipidstoff und ein tensid auf lanolinbasis enthalten und ihre verwendung
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
MY129150A (en) Novel sulfamides
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
ME01631B (de) Medizinische aerosolformulierungen
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
ATE303363T1 (de) 4-aminopyridinderivate, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
CA2361402A1 (en) Bis-sulfonamides
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
FR2734481B1 (fr) Pseudo-emulsions stabilisees et leur procede de preparation
NO20010940D0 (no) TAN-1057 derivater
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
BR0011100A (pt) Formulação lìquida de ditiocarbamato essencialmente anidra, e, uso da mesma
EP0808842A3 (de) Alkyl-2-acetamido-2-desoxy-gluco-pyranosid-uronsäuren und -Derivate, ihre Herstellung sowie ihre Verwendung als Tenside in kosmetischen und pharmazeutischen Zubereitungen
DE59401618D1 (de) Präparate aus crataegus-arten, arzneimittel und ihre verwendung zur verhinderung des plötzlichen herztodes sowie von reperfusions-bedingten cardiovaskulären schädigungen
DE69812086D1 (de) Glykosylierte-ginkgolid-derivate, ihre verwendung als arzneimitteln und pharmazeutische zubereitungen die sie enthalten
AR010019A1 (es) Uso de por lo menos un principio activo, capaz de ser obtenido por extraccion de ginkgo biloba para la preparacion de composiciones farmaceuticas,y metodo de tratamiento cosmetico de pieles hiperreactivas.
KR970032819A (ko) 미백화장료 조성물
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
DE69727507D1 (de) Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition